Ultrasound is an effective imaging technique that is used by medical professionals for non-invasively imaging various tissues inside a body of the patient. However, in some cases, ultrasound cannot be effectively used. For example, ultrasound cannot be used to effectively penetrate a cortical bone. The transition to cortical bone from soft tissue outside when using an ultrasound transducer aberrates ultrasound waves, rendering it impossible to refocus for the purposes of detection and/or imaging. As such, many potential medical diagnostic and/or treatment methods cannot be used, leaving medical professionals to rely on other tools for diagnosis, imaging, treatment, etc., e.g., a magnetic resonance imaging (MRI) which is costly.
One such challenging diagnostic problem that cannot be currently diagnosed using ultrasound is rheumatoid arthritis (RA). RA is a debilitating, chronic systemic autoimmune disease of the synovial joints that leads to joint destruction and loss of function for ˜1% of the worldwide population. Early bone damage due to RA is correlated with poor long-term patient outcomes, and bone marrow lesions—especially, bone marrow edema (BME)—are a useful prognostic indicator of disabling RA. Because ultrasound cannot cross cortical bone to image the bone marrow within, MRI has been used to detect BME (at a significant cost). However, MRI cannot be used in every case. For example, MRI cannot be used on patients with joint replacement and other types of metal implants. Further, some patients also encounter adverse side effects from the gadolinium contrast agent administered prior to MRI procedures. Hence, there is a need for an improved approach for using ultrasound to diagnose, image, treat, etc. various medical conditions.
In some implementations, the current subject matter relates to a method for fabricating a non-resonant acoustic metamaterial (NRAM). The method may include forming a layer of a first material on a first substrate, forming a layer of a second material on the layer of the first material to produce a stacked layer of first and second materials, exposing at least a portion of the stacked layer of first and second materials to a radiation, removing the exposed portion of the second material from the stacked layer of first and second materials, and forming a cavity using the removed exposed portion of the second material, wherein the cavity includes a membrane formed from at least a portion of the first material.
In some implementations, the current subject matter may include one or more of the features disclosed herein including following optional features. The method may include removing at least a portion of the first substrate subsequent to the forming of the layer of a second material on the layer of the first material. The method may also include transferring the stacked layer of the first and second materials onto a second substrate.
In some implementations, the stacked layer of the first and second materials may include a plurality of alternating layers of the first material and the second material. In some implementations, the removing may further include removing a plurality of layers of the second materials from the stacked layer of the first and second materials while retaining a plurality of first materials. The cavity may include a plurality of portions of layers of the first material forming a plurality of membranes. Further, the plurality of membranes may be configured to resonate at a predetermined operating frequency and configured to shift phase and/or amplitude of one or more ultrasound waves passing through the cavity. The predetermined operating frequency may be in a range of approximately 100 KHz to approximately 250 MHz.
In some implementations, the first material may be a hard material and the second material is a soft material. The first material may include at least one of the following: a silicon oxide, a silicon nitride, a graphene, a diamond, a metal nitride, a metal carbide, a silicon carbide, a metal oxide, a metal oxide bilayer, a silicon oxide bilayer, metal nitride bilayer, silicon nitride bilayer, aluminum nitride, aluminum carbide, aluminum oxide, aluminum oxide bilayer, aluminum nitride bilayer, chromium nitride, chromium carbide, chromium oxide, chromium oxide bilayer, chromium nitride bilayer, and any combinations thereof. Any other metal may also be used. The second material may include at least one of the following: a polymethyl methacrylate (PMMA) material, SU-8 material, silicon, polymer, and any combinations thereof.
In some implementations, the cavity may be filled with at least one of the following: a fluid, a gas, and any combinations thereof.
In some implementations, the cavity may be configured to be connected to at least another cavity formed in at least another second layer and further configured to be separated from at least another cavity by at least one of: the membrane and at least another membrane.
In some implementations, the current subject matter relates to a non-resonant acoustic metamaterial apparatus that may be formed in accordance with the method above. The apparatus may include a layer of a first material on a first substrate, a layer of a second material formed on the layer of the first material to produce a stacked layer of first and second materials and a cavity. The cavity may be formed by exposing at least a portion of the stacked layer of first and second materials to a radiation, removing the exposed portion of the second material from the stacked layer of first and second materials, and forming the cavity using the removed exposed portion of the second material, wherein the cavity includes a membrane formed from at least a portion of the first material. The apparatus may include some of the optional features discussed above.
In some implementations, the current subject matter relates to an ultrasound system that may include an ultrasound transducer and the non-resonant acoustic metamaterial coupled to the ultrasound transducer having features discussed above.
In some implementations, there is provided a method for rendering cortical bone that is transparent to conventional ultrasound. The method may include introducing an acoustic metamaterial layer between a standard ultrasound clinical imaging probe and the soft tissues adjacent to the target bone marrow imaging region, thereby compensating for the subsequent aberration of the cortical bone as the ultrasound makes its way to and from the marrow and trabecular structure within. The acoustic metamaterial layer may be formed from a non-resonant acoustic metamaterial (NRAM) that is suitable for the transmission of ultrasound at clinically relevant frequencies through a cortical bone analog.
Implementations of the current subject matter can include, but are not limited to, systems and methods consistent including one or more features are described as well as articles that comprise a tangibly embodied machine-readable medium operable to cause one or more machines (e.g., computers, etc.) to result in operations described herein. Similarly, computer systems are also described that may include one or more processors and one or more memories coupled to the one or more processors. A memory, which can include a computer-readable storage medium, may include, encode, store, or the like one or more programs that cause one or more processors to perform one or more of the operations described herein. Computer implemented methods consistent with one or more implementations of the current subject matter can be implemented by one or more data processors residing in a single computing system or multiple computing systems. Such multiple computing systems can be connected and can exchange data and/or commands or other instructions or the like via one or more connections, including a connection over a network (e.g. the Internet, a wireless wide area network, a local area network, a wide area network, a wired network, or the like), via a direct connection between one or more of the multiple computing systems, etc.
The details of one or more variations of the subject matter described herein are set forth in the accompanying drawings and the description below. Other features and advantages of the subject matter described herein will be apparent from the description and drawings, and from the claims. While certain features of the currently disclosed subject matter are described for illustrative purposes in relation to the rendering of objects using ultrasound, it should be readily understood that such features are not intended to be limiting. The claims that follow this disclosure are intended to define the scope of the protected subject matter.
The accompanying drawings, which are incorporated in and constitute a part of this specification, show certain aspects of the subject matter disclosed herein and, together with the description, help explain some of the principles associated with the disclosed implementations. In the drawings,
In some implementations, the current subject matter provides an ability to make it possible to effectively transmit ultrasound waves across different types of tissues (e.g., cortical bone, and/or other tissues) for the purposes of imaging, detection, diagnosis, treatment, etc. using ultrasound. The current subject matter relates to a non-resonant acoustic metamaterial (NRAM) layer that may be positioned between a standard ultrasound clinical imaging probe and soft and/or any other tissues of the patient (e.g., adjacent to the target bone marrow imaging region). Such non-resonant acoustic metamaterial may be configured to compensate for any subsequent aberration (e.g., as the ultrasound waves traverse cortical bone on its way to and from the marrow and trabecular structure within). The NRAM materials may be used with a variety of ultrasound frequencies for traversal of various tissues (e.g., soft tissue, cortical bone, etc.), objects, etc. The current subject matter's system, method, material, etc. may also be used for a variety of purposes, including medical as well as non-medical purposes and/or uses.
For ease of illustration only, the following description will be presented in connection with using the NRAM material together with an ultrasound probe for transmission of ultrasound waves at various frequencies through a cortical bone. However, as can be understood and as stated above, the current subject matter may be used for any other purposes (e.g., neurointervention to osteoarthritis, myeloma, peripheral musculoskeletal injuries, imaging of any human/animal/organic/inorganic/etc. tissues, any objects, etc.).
In some implementations, the NRAM material may be fabricated via a combination of nanofabrication methods and/or guidance of non-contact acoustic measurements. The NRAM material may be a layer that may possess a negative density and stiffness along the ultrasound wave propagation direction. The NRAM materials may be a composite with regularly-spaced, fluid-filled internal cavities having a size smaller than the wavelength of the ultrasound. When ultrasound waves pass through the NRAM material from an ultrasound source to the target tissue and back to the source (i.e., each way via other soft tissue and hard tissue (e.g., the cortical bone)), the NRAM material may be configured to compensate for the aberration (or incoherency) that may induced by the interfering tissues and/or objects (e.g., cortical bone and/or other tissues). Thus, various implementations of the current subject matter may enable use of ultrasound to characterize, image, treat, etc. tissues beyond interfering tissues and/or objects (e.g., cortical bone, other soft tissues, etc.). Through the design and construction of NRAM attached to an ultrasound transducer, in some exemplary, non-limiting implementations, the cortical bone may be rendered transparent to the ultrasound, thereby facilitating characterization, imaging, treatment, etc. of the bone marrow.
In some implementations, the NRAM material may be fabricated using 3-dimensional nanofabrication methods. The methods may be based on stacking and/or on multilayer nanostructuring techniques, which in some exemplary, non-limiting, implementations, may have a resolution of less than 1 μm, which is less than ultrasound-relevant wavelengths. The NRAM material may be configured to be used with ultrasound frequencies from approximately 100 kHz to at least 250 MHz.
In some exemplary, non-limiting implementations, the NRAM material, when used together with an ultrasound transducer, may be used to characterize and/or diagnose presence of bone marrow lesions via quantitative ultrasound (QUS). Further, NRAM material together with an ultrasound transducer may be used to detect, diagnose, etc. BME in the small joints of RA patients with and/or without BME. As can be understood, the NRAM material when used together with any ultrasound system may be used for the purposes of scanning, imaging, detection, diagnosis, treatment, etc. of objects, tissues, materials, etc. (whether animate and/or inanimate).
In some implementations, the current subject matter's NRAM material may be used for efficiently passing acoustic waves through high acoustic impedance materials (such as bone and/or metal objects), surrounded by relatively low acoustic impedance materials (e.g., tissue, water, etc.). The NRAM material may have a substantially crystalline structure (e.g., millimeter to micrometer-scale structure) that may include high and/or low density elastic media at dimensions that may be smaller than the wavelength of the acoustic waves. The current subject matter's NRAM material may produce negative density and/or stiffness values in a desired direction by having one or more cavities disposed therein.
In some exemplary, non-limiting implementations, the current subject matter's NRAM material may have one or more layers approximately 50 nm thick and lateral features approximately 250 nm. The NRAM material may be configured to enable passing of up to 250 MHz ultrasound through 400 μm of cortical bone to generate coherent ultrasound waves, facilitate bone marrow characterization, etc. Upon reflection, the ultrasound waves may reform in a coherent fashion to generate imagery. Thus, the current subject matter's NRAM material may be configured to operate in both directions (from source to target and from target to source).
Referring to
To form cavities, the stacked layer 108 may be exposed to an electron beam 110, as shown in
In some implementations, the stacked layer 108 may include any number of layers of the soft material 106 and stiff material 104. The number of layers of materials 104, 106 may be selected in accordance with a particular ultrasound application, ultrasound probe, and/or any other factors. Referring to
In some implementations, the layers 108 may be deposited and/or structured on a prefabrication substrate 102 and then transferred onto a final stacking substrate 103 (as shown in
In some exemplary, non-limiting, implementations, the NRAM material may controllably scatter ultrasound waves prior to passage through skin, muscle, bone, and/or any other tissues and/or objects to compensate for the presence of the cortical bone along the ultrasound wave propagation path, thereby producing a coherent, focused ultrasound beam after passage through the cortical bone for characterization, imaging, etc. of tissue beyond it. The NRAM material may be configured to scatter the ultrasound waves to generate a plurality of foci of ultrasound at the inner surface of the cortical bone, each of which may constructively interfere with each other to generate coherent ultrasound wave to propagate through the bone to the marrow tissue within. Similarly, the NRAM material may be configured to focus the reflected ultrasound waves. In particular, a point or planar ultrasound transducer may generate a pulse that propagates through the NRAM material, skin, muscle, bone, etc. and to the tissue beyond, and then may detect the returning ultrasound signal from that tissue through these interceding layers as if the bone is transparent to it. The current subject matter system may be further configured to quantify the tissue's acoustic properties beyond the cortical bone, and particularly, the relative attenuation and backscatter coefficients, to generate one or more planar images.
At 404, an ultrasound wave is generated by the ultrasound probe/transducer and transmitted toward a target tissue (e.g., marrow tissue beyond cortical bone). The ultrasound wave may be initially transmitted through the NRAM material, which may be configured to generate a coherent ultrasound wave for penetration through the skin, soft tissue, and cortical bone to reach the target tissue, at 406.
At 408, the ultrasound wave may be reflected and transmitted toward the receiver in the ultrasound probe/transducer. The reflected wave may be again passed through the NRAM material, at 410, which may shift at least of one of a phase and an amplitude of the wave to generate a coherent beam.
At 412, an image may be generated by the ultrasound probe/transducer, upon receiving the reflected coherent beam. In some implementations, the NRAM material's sensitivity to variations in bone, tissue, etc. may be weak, thereby allowing a combination of the NRAM material and the ultrasound probe to be independent of the various factors that are routinely associated with conventional ultrasound probes.
In some exemplary implementations, referring back to
b
e
=b
o[0−S(2AdρLef)]
The effective density of the material may be made strongly anisotropic by the relative width of the walls to cavities, to the extent that a negative density may be obtained along the ultrasound propagation direction.
In some implementations, the configuration of the NRAM material shown in
Image 502c illustrates use of current subject matter's NRAM material (“Metamaterial”) with no abberator (i.e., cortical bone) present in the path of the ultrasound wave. Similar to image 502a, the generated image is clear. Hence, presence of the NRAM material does not affect image generation when there is no abberator. Image 502d illustrates use of the NRAM material when abberator (i.e., cortical bone) is present in the path of the transmitted ultrasound wave. Contrary to the image 502b, the NRAM material may allow the ultrasound wave to pass through the abberator to generate a clear ultrasound image. The NRAM material may operate without resonance, unlike traditional forms of acoustic metamaterials, to reduce their sensitivity to small changes in frequency, long range ordering, adjacent material properties, and/or morphology, which is important for various clinical uses.
In some implementations, the NRAM material may incorporate suspended silicon nitride (or any other materials, e.g., a graphene, a diamond, a metal nitride, a metal carbide, a silicon carbide, a metal oxide, a metal oxide bilayer, a silicon oxide bilayer, metal nitride bilayer, silicon nitride bilayer, aluminum nitride, aluminum carbide, aluminum oxide, aluminum oxide bilayer, aluminum nitride bilayer, chromium nitride, chromium carbide, chromium oxide, chromium oxide bilayer, chromium nitride bilayer, etc.; any other metals and/or materials may be used) membranes supported on microstructure pillars using multi-stack processing and thin film transfer to create cavities (or cuboids) having a size in a range of approximately 200 nm to approximately 20 μm that may be used for anisotropic sound propagation. High-resolution electron beam lithography and/or any other methods may be used to create cavity having the above dimensions. As stated above, the cavities may be created using tough, stiff, and atomically thin graphene. The nanoscale NRAM material may be configured to operate with ultrasound waves having higher operating frequencies (as compared to the conventional materials).
In some implementations, to fabricate a device having the NRAM material for use with an ultrasound transducer/probe, one or more individual cuboid cells may be created. A finite element analysis (FEA, ANSYS) of individual cuboid unit cells may be conducted to determine a net density and stiffness of the NRAM material using an extensive symmetry in the structure. The individual unit cell model of the NRAM material structure may be used to determine an effect of geometry and/or material choices on the NRAM material and acoustic wave propagation through it.
The NRAM's characteristics determined from one unit cell model may then be applied to the following, two-dimensional solid media in-silico representation of the entire multicellular material, together with a viscoelastic layer of tissue, an elastic layer of cortical bone, and a viscoelastic layer of bone marrow. This model may be used to identify an ability of the material to transmit coherent ultrasound in time-domain FEA analyses, applied as a displacement boundary condition at the NRAM's outer surface, to the opposite side of the model, the surface of the bone marrow. By applying either a perfectly reflecting and/or perfectly absorbing boundary condition at the bone marrow surface, it may be possible to determine an ability of the material to aid in transmission and/or detection of ultrasound through the system. The current subject matter system may be configured to compute both A-scan (amplitude versus time) and/or C-scan (spatial imagery) representations that may be used to assess the NRAM material for the purposes of increasing a return signal intensity and/or coherence from the bone marrow and reducing them from the tissue-cortical bone interface. This model may also be used for determination of the sensitivity of the NRAM to the thicknesses and material properties of the tissue, bone, and marrow, and/or the misalignment of the layers with respect to each other.
As discussed above, the NRAM material may be fabricated in a stacked form that may be, in some exemplary implementations, be approximately 1 mm thick, which may be used for ultrasound wave to penetrate into the bone marrow. The exemplary fabrication process may be performed by nanostructuring 1-10 μm thick multilayer films and thin film transferring and stacking of these multilayer films to form the final 0.1 to 1 mm thick NRAM material. A stack of alternating thin films of silicon nitride (SiN) and of acrylic (e.g., PMMA) may be initially created, as discussed above. SiN is a hard, transparent and a stable material with a Young's modulus (E) of 350 GPa, while PMMA is relatively soft (E˜2 GPa) but patternable via electron-beam radiation and thus, may be used for nanostructuring to form the NRAM cuboids within the 1-10 μm thick multilayer structure. The e-beam radiation may expose selected regions of the PMMA within the intercalated SiN-PMMA stack. The exposed PMMA may be then removed via one or more vent ports positioned in the same plane as the cuboid structures. These same vent ports may be used to provide negative density for ultrasound passing across the NRAM material, and the cuboid structure may provide a desired negative stiffness. Since layers 0.1 to 1 mm in thickness may be needed to compensate for the cortical bone layer, 100-1000 (or any other number) of these multilayer films may be stacked using a combinatorial process and a final bond of the layers may be performed to form the NRAM material. Next, an alignment may be performed to transfer and stack the modules. In some exemplary implementations, if necessary, the layers may be further aligned and/or sealed, however, because the one or more NRAM material size features are smaller than the wavelength of the ultrasound, the NRAM material and its corresponding functionalities may be able to perform its intended functionalities even if layers are misaligned.
In some implementations, the NRAM material may be used to make up to approximately 0.4 mm (or any other thickness) of cortical bone transparent to ultrasound at frequencies of approximately 250 MHz (or any other frequency discussed above), including the interceding soft tissue, enabling assessment of the state of bone marrow within, with useful experimental and analysis data describing the material characteristics and expected behavior in ultrasound phantoms.
In some implementations, to allow venting of each nanoscale cell, the NRAM material's cells may include a gradient in the vent size laterally across each layer of the NRAM material. Further, through-thickness venting and/or lateral isolation of groups of unit cuboid cells with gaps between them may be used for venting purposes.
In some implementations, a quantitative ultrasound (QUS) methods for both NRAM performance and bone marrow characterization may be used to provide frequency-dependent attenuation (AC) and backscatter coefficients (BSC) for the useful bandwidth of ultrasound transducers for ex vivo and/or in vivo application. AC and BSC are frequency-dependent fundamental properties of tissue, reflecting tissue's composition and structure. QUS may acquire a raw beam-formed radio frequency ultrasound (RF) echo data, correct for machine-and/or transducer-dependent factors, and/or correct for overall attenuation (it may be used for a variety of ex- and in vivo pre-clinical and/or clinical applications).
In some implementations, the current subject matter's NRAM material may be configured to avoid narrow band operation and/or high losses that may be typically associated with resonant metamaterials. NRAM material may be configured to have a frequency window Δf/fo of approximately 5-10% to tune modulus and density, which may be advantageous in view of skull variations in thickness and/or composition. As described above, the NRAM material may be include one or more acoustic wave-guiding cavities having the following components: membranes 808 producing negative density and open channels 806 giving negative modulus.
From the above equations, NRAM operating frequencies and sizes of unit cells may be determined (e.g., operating frequencies of 1-250 MHz may require 100-10 μm unit cells. By way of a non-limiting example, the NRAM material may be configured to have an operating frequency of 5.5 MHz, having density ρ[M] approximately −4000 kg/m3, K[M] approximately −10 GPa, channel diameter of approximately 20 μm, cavity length of approximately 20 μm, SiNx membrane being approximately 750 nm thick, and an open channel (channel 122 as shown in
Referring to
An alternative process 920, as shown in
In some implementations, the NRAM material 1006 may be configured to be placed directly on the skin of the object 1008 (e.g., via an ultrasound gel). The probe/transducer 1004 may be configured to generate one or more ultrasound waves 1014 that may be configured to pass through the NRAM material 1006 and toward a target tissue 1012, where the target tissue (e.g., marrow) 1012 may be located “behind” an abberator tissue 1010 (e.g., cortical bone). The NRAM material 1006 may be configured to shift phase and/or amplitude of the ultrasound waves 1014 passing through it to penetrate the abberator tissue 1010 to reach the target tissue 1012 and be reflected back to through the abberator tissue 1012, where the NRAM material may also focus and/or shift phase and/or amplitude of the reflected waves toward the receiver in the probe/transducer for processing by the system 1002.
In some implementations, the current subject matter may include one or more of the following optional features. The method may include removing at least a portion of the first substrate subsequent to the forming of the layer of a second material on the layer of the first material. The method may also include transferring the stacked layer of the first and second materials onto a second substrate.
In some implementations, the stacked layer of the first and second materials may include a plurality of alternating layers of the first material and the second material. In some implementations, the removing may further include removing a plurality of layers of the second materials from the stacked layer of the first and second materials while retaining a plurality of first materials. The cavity may include a plurality of portions of layers of the first material forming a plurality of membranes. Further, the plurality of membranes may be configured to resonate at a predetermined operating frequency and configured to shift phase and/or amplitude of one or more ultrasound waves passing through the cavity. The predetermined operating frequency may be in a range of approximately 100 KHz to approximately 250 MHz.
In some implementations, the first material may be a hard material and the second material is a soft material. The first material may include at least one of the following: a silicon oxide, a silicon nitride, a graphene, a diamond, a metal nitride, a metal carbide, a silicon carbide, a metal oxide, a metal oxide bilayer, a silicon oxide bilayer, metal nitride bilayer, silicon nitride bilayer, aluminum nitride, aluminum carbide, aluminum oxide, aluminum oxide bilayer, aluminum nitride bilayer, chromium nitride, chromium carbide, chromium oxide, chromium oxide bilayer, chromium nitride bilayer, and any combinations thereof. Any other metals and/or materials may be used. The second material may include at least one of the following: a polymethyl methacrylate (PMMA) material, SU-8 material, silicon, polymer, and any combinations thereof.
In some implementations, the cavity may be filled with at least one of the following: a fluid, a gas, and any combinations thereof.
In some implementations, the cavity may be configured to be connected to at least another cavity formed in at least another second layer and further configured to be separated from at least another cavity by at least one of: the membrane and at least another membrane.
In some implementations, the current subject matter relates to a non-resonant acoustic metamaterial apparatus that may be formed in accordance with the discussion above (e.g., method 1100 shown in
In some implementations, the current subject matter relates to an ultrasound system that may include an ultrasound transducer and the non-resonant acoustic metamaterial coupled to the ultrasound transducer having features discussed above.
Without in any way limiting the scope, interpretation, or application of the claims appearing below, a technical effect of one or more of the example embodiments disclosed herein may provide an ability to allow imaging of objects, tissues, materials, etc. using ultrasound waves, where the objects may be located behind an interfering body (e.g., in case of a bone marrow, a cortical bone, etc.). This advantage may be achieved through controllable scattering of ultrasound waves prior to passage through interfering objects to compensate for the presence of the such objects along the ultrasound wave propagation path, thereby producing a coherent, focused ultrasound beam after passage through the objects for characterization, imaging, etc. of objects beyond it.
One or more aspects or features of the subject matter described herein can be realized in digital electronic circuitry, integrated circuitry, specially designed application specific integrated circuits (ASICs), field programmable gate arrays (FPGAs) computer hardware, firmware, software, and/or combinations thereof. These various aspects or features can include implementation in one or more computer programs that are executable and/or interpretable on a programmable system including at least one programmable processor, which can be special or general purpose, coupled to receive data and instructions from, and to transmit data and instructions to, a storage system, at least one input device, and at least one output device. The programmable system or computing system may include clients and servers. A client and server are generally remote from each other and typically interact through a communication network. The relationship of client and server arises by virtue of computer programs running on the respective computers and having a client-server relationship to each other.
These computer programs, which can also be referred to as programs, software, software applications, applications, components, or code, include machine instructions for a programmable processor, and can be implemented in a high-level procedural and/or object-oriented programming language, and/or in assembly/machine language. As used herein, the term “machine-readable medium” refers to any computer program product, apparatus and/or device, such as for example magnetic discs, optical disks, memory, and Programmable Logic Devices (PLDs), used to provide machine instructions and/or data to a programmable processor, including a machine-readable medium that receives machine instructions as a machine-readable signal. The term “machine-readable signal” refers to any signal used to provide machine instructions and/or data to a programmable processor. The machine-readable medium can store such machine instructions non-transitorily, such as for example as would a non-transient solid-state memory or a magnetic hard drive or any equivalent storage medium. The machine-readable medium can alternatively, or additionally, store such machine instructions in a transient manner, such as for example, as would a processor cache or other random access memory associated with one or more physical processor cores.
The subject matter described herein can be embodied in systems, apparatus, methods, and/or articles depending on the desired configuration. The implementations set forth in the foregoing description do not represent all implementations consistent with the subject matter described herein. Instead, they are merely some examples consistent with aspects related to the described subject matter. Although a few variations have been described in detail above, other modifications or additions are possible. In particular, further features and/or variations can be provided in addition to those set forth herein. For example, the implementations described above can be directed to various combinations and subcombinations of the disclosed features and/or combinations and subcombinations of several further features disclosed above. In addition, the logic flows depicted in the accompanying figures and/or described herein do not necessarily require the particular order shown, or sequential order, to achieve desirable results. Other implementations may be within the scope of the following claims.
The present application claims priority to U.S. Provisional Patent Appl. No. 62/747,641 to Guma et al., filed Oct. 18, 2018, and entitled “Method for Rendering Cortical Bone Transparent to Ultrasound”, and incorporates its disclosure herein by reference in its entirety.
This invention was made with government support under D18AP00062 awarded by Defense Advanced Research Projects Agency. The government has certain rights in the invention.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2019/057047 | 10/18/2019 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62747641 | Oct 2018 | US |